Achmea Investment Management B.V. Bristol Myers Squibb CO Transaction History
Achmea Investment Management B.V.
- $7.75 Billion
- Q2 2025
A detailed history of Achmea Investment Management B.V. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Achmea Investment Management B.V. holds 869,050 shares of BMY stock, worth $40.5 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
869,050
Previous 665,947
30.5%
Holding current value
$40.5 Million
Previous $40.6 Million
0.96%
% of portfolio
0.52%
Previous 0.59%
Shares
32 transactions
Others Institutions Holding BMY
# of Institutions
2,665Shares Held
1.6BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...